Right Time Eating and Delayed Time Eating for Colorectal Cancer
(AFT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you must stop all current medications, but you cannot participate if you regularly use medications that affect melatonin, like melatonin supplements, certain anti-nausea drugs, or sleep aids, in the four weeks before the study.
What data supports the effectiveness of the treatment Right Time Eating and Delayed Time Eating for Colorectal Cancer?
Is the treatment of Right Time Eating and Delayed Time Eating for Colorectal Cancer safe for humans?
How does the Right Time Eating and Delayed Time Eating treatment for colorectal cancer differ from other treatments?
This treatment is unique because it focuses on the timing of food intake to potentially influence colorectal cancer pathways, unlike traditional treatments that may focus on medication or surgery. It explores how eating at the right or wrong times can affect the body's internal clock (circadian rhythm) and its interaction with alcohol consumption, which is a known risk factor for colorectal cancer.134510
What is the purpose of this trial?
The purpose of this study is to study the impact of Western lifestyle, including moderate alcohol consumption and delayed eating patterns on studying individuals' susceptibility to colorectal cancer. This study aims to increase our ability to identify individuals at risk for colorectal cancer in the future.Each subject will experience four conditions (each for one week in duration with a week +/- 2 days wash-out in between): (1) "right-time eating" / no alcohol, (2) "right-time eating" / with alcohol, (3) "delayed-eating" / no alcohol, (4) "delayed-eating" / with alcohol. The order of experiments will be randomized \[concealed randomization\]. All subjects will undergo unprepped sigmoidoscopy after each week of intervention. In Aim 2, all subjects will have an option to undergo a 24h circadian assessment in the Biological Rhythms Research Lab after each week of intervention. The Investigator will assess (i) central circadian rhythms by collecting hourly salivary samples for melatonin assays and (ii) peripheral rhythm in the intestinal tract by buccal swabs once every 2h (12 time points) as well as by rectal sampling twice (every 12 hr). For Aim 3, sigmoidoscopy without sedation will be used to obtain colonic samples as the safe method compared to colonoscopy, which has some small but finite risks associated with the procedure (e.g, bleeding or perforation) as well as sedation.
Research Team
Ali Keshavarzian, MD
Principal Investigator
Rush University Medical Center
Eligibility Criteria
This trial is for adults over 21 who've had advanced tubular adenoma in the past year. It's not for those with sleep apnea, alcohol disorders, genetic predispositions to colorectal cancer, inflammatory bowel diseases, or conditions affecting the circadian system like chronic renal failure or night shift work.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants undergo four different eating and alcohol consumption conditions, each lasting one week, with a wash-out period in between.
Follow-up
Participants are monitored for safety and effectiveness after intervention
Treatment Details
Interventions
- Alcohol
- Delayed time eating
- Right time eating
- Sigmoidoscopy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor